Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223
Authors
Keywords
-
Journal
PROSTATE
Volume 77, Issue 3, Pages 245-254
Publisher
Wiley
Online
2016-11-01
DOI
10.1002/pros.23272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial
- (2016) Fred Saad et al. LANCET ONCOLOGY
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial
- (2016) Christopher R. Heery et al. Oncotarget
- Potentiation of Peptide Receptor Radionuclide Therapy by the PARP Inhibitor Olaparib
- (2016) Julie Nonnekens et al. Theranostics
- Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy
- (2016) B. Farsaci et al. Cancer Immunology Research
- Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
- (2015) S. Gillessen et al. ANNALS OF ONCOLOGY
- Abstract 1800: The PARP inhibitor, rucaparib enhances the antitumor activity of177Lu-DOTA-octreotate radionuclide therapy in preclinical models of neuroendocrine tumor
- (2015) Carleen Cullinane et al. CANCER RESEARCH
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Mitotic quiescence, but not unique “stemness,” marks the phenotype of bone metastasis-initiating cells in prostate cancer
- (2015) Ning Wang et al. FASEB JOURNAL
- The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer
- (2015) Ning Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Prognostic Factors in Patients Treated with 223Ra: The Role of Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT in Predicting Overall Survival
- (2015) E. C. Etchebehere et al. JOURNAL OF NUCLEAR MEDICINE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer
- (2015) Christopher R. Heery et al. JAMA Oncology
- A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease
- (2014) Robert Coleman et al. BREAST CANCER RESEARCH AND TREATMENT
- Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets
- (2014) M M Wattenberg et al. BRITISH JOURNAL OF CANCER
- Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone
- (2014) P. D. Ottewell et al. ENDOCRINE-RELATED CANCER
- Prostate Cancer Cells Preferentially Home to Osteoblast-rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models
- (2014) Ning Wang et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
- (2014) Oliver Sartor et al. LANCET ONCOLOGY
- Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases
- (2014) X. Wan et al. Science Translational Medicine
- Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223
- (2014) Ragnhild Nome et al. Scandinavian Journal of Urology
- Survival Benefit With Radium-223 Dichloride in a Mouse Model of Breast Cancer Bone Metastasis
- (2013) Mari I. Suominen et al. JNCI-Journal of the National Cancer Institute
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination Therapy with Local Radiofrequency Ablation and Systemic Vaccine Enhances Antitumor Immunity and Mediates Local and Distal Tumor Regression
- (2013) Sofia R. Gameiro et al. PLoS One
- Abscopal Regression of Antigen Disparate Tumors by Antigen Cascade After Systemic Tumor Vaccination in Combination with Local Tumor Radiation
- (2012) James W. Hodge et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial
- (2012) Christopher J Logothetis et al. LANCET ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients
- (2010) N. J. Nesslinger et al. CLINICAL CANCER RESEARCH
- Improved Endpoints for Cancer Immunotherapy Trials
- (2010) A. Hoos et al. JNCI-Journal of the National Cancer Institute
- Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
- (2009) T. M. Morgan et al. CLINICAL CANCER RESEARCH
- Vaccination with a Recombinant Saccharomyces cerevisiae Expressing a Tumor Antigen Breaks Immune Tolerance and Elicits Therapeutic Antitumor Responses
- (2008) E. K. Wansley et al. CLINICAL CANCER RESEARCH
- The Use of Chelated Radionuclide (Samarium-153-Ethylenediaminetetramethylenephosphonate) to Modulate Phenotype of Tumor Cells and Enhance T Cell-Mediated Killing
- (2008) M. Chakraborty et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started